[
    {
        "question": "Which of the following hemoglobins are synthesized during embryonic life before the tenth week of intrauterine life?",
        "options": ["Haemoglobin Gower I", "Haemoglobin Gower II", "Haemoglobin Portland", "HbA", "HbF"],
        "answer": ["T", "T", "T", "F", "F"]
    },
    {
        "question": "Which of the following reactions occur in the mitochondria during haem synthesis?",
        "options": ["Formation of Î´-aminolevulinic acid (ALA)", "Oxidation of protoporphyrinogen IX", "Formation of porphobilinogen", "Conversion of protoporphyrin IX to haem", "Decarboxylation of uroporphyrinogen III"],
        "answer": ["T", "T", "F", "T", "F"]
    },
    {
        "question": "Which components are required for the first step of haem synthesis?",
        "options": ["Succinyl-CoA", "Glycine", "Pyridoxal phosphate", "Zinc", "Iron in the ferric state (Fe3+)"],
        "answer": ["T", "T", "T", "T", "F"]
    },
    {
        "question": "Lead toxicity in haem synthesis inhibits:",
        "options": ["ALA synthase", "Ferrochelatase", "ALA dehydratase", "Porphobilinogen deaminase", "Uroporphyrinogen decarboxylase"],
        "answer": ["F", "F", "T", "F", "F"]
    },
    {
        "question": "Globin synthesis occurs in:",
        "options": ["Cytosol", "Ribosomes", "Mitochondria", "Endoplasmic reticulum", "Nucleus"],
        "answer": ["T", "T", "F", "F", "F"]
    },
    {
        "question": "Which gene cluster is located on chromosome 16?",
        "options": ["Alpha-like cluster", "Beta-like cluster", "Gamma-globin genes", "Delta-globin genes", "Epsilon-globin genes"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Which of the following represents haemoproteins?",
        "options": ["Haemoglobin", "Myoglobin", "Cytochrome P450", "Catalases", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "The regulation of haemoglobin synthesis involves:",
        "options": ["Abundance of haem", "Availability of substrates", "Activity of ALAS enzyme", "Iron levels", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Which of the following are terminal codons during translation?",
        "options": ["UAA", "UAG", "UGA", "AUG", "UGG"],
        "answer": ["T", "T", "T", "F", "F"]
    },
    {
        "question": "What is the function of 2,3-DPG in oxygen transport?",
        "options": ["Increases oxygen affinity", "Shifts dissociation curve to the right", "Favors deoxygenation", "Binds to the beta cleft", "Prevents oxygen release"],
        "answer": ["F", "T", "T", "T", "F"]
    },
    {
        "question": "Which of the following are functions of haemoglobin?",
        "options": ["Oxygen transport", "Carbon dioxide removal", "Vascular tone control", "Acid buffering", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "The sigmoid oxygen dissociation curve of haemoglobin is influenced by:",
        "options": ["pH", "Temperature", "2,3-DPG concentration", "Carbon monoxide binding", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Which structural level of haemoglobin involves folding of polypeptides into a pseudosphere?",
        "options": ["Primary structure", "Secondary structure", "Tertiary structure", "Quaternary structure", "None of the above"],
        "answer": ["F", "F", "T", "F", "F"]
    },
    {
        "question": "Haemoglobinopathies include:",
        "options": ["Sickle cell disorders", "Thalassemias", "Porphyrias", "Sideroblastic anaemias", "All of the above"],
        "answer": ["T", "T", "F", "F", "F"]
    },
    {
        "question": "The Bohr effect is described as:",
        "options": ["Decreased oxygen affinity at low pH", "Increased oxygen affinity at high pH", "Shift of dissociation curve to the left", "Enhanced oxygen binding in acidic environments", "Reduced CO2 binding at high pH"],
        "answer": ["T", "T", "F", "F", "F"]
    },
    {
        "question": "Methaehaemoglobin is characterized by:",
        "options": ["Iron in the ferric state (Fe3+)", "Inability to bind oxygen", "High levels in normal individuals", "Presence in CO poisoning", "All of the above"],
        "answer": ["T", "T", "F", "T", "F"]
    },
    {
        "question": "Which of the following genes are part of the beta-like cluster?",
        "options": ["Epsilon", "Gamma G", "Gamma A", "Delta", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Haemoglobin's quaternary structure includes:",
        "options": ["Tetrahedral arrangement", "Two alpha and two beta chains", "Inter-subunit bonds", "Oxygenation-dependent structural changes", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Which of the following are clinical correlates of haemoglobin synthesis disorders?",
        "options": ["Porphyrias", "Sideroblastic anaemias", "Sickle cell disease", "Thalassemias", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "The alpha-like cluster genes on chromosome 16 include:",
        "options": ["Zeta", "Alpha 1", "Alpha 2", "Theta", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Which chromosome contains the beta-like globin gene cluster?",
        "options": ["Chromosome 11", "Chromosome 16", "Chromosome 21", "Chromosome 7", "Chromosome 19"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Globin synthesis is tightly regulated to prevent which of the following?",
        "options": ["Excess accumulation of protoporphyrin IX", "Damage to red blood cells", "Unbalanced globin and haem production", "Shortened cell lifespan", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "What is the main function of the alpha-like cluster located on chromosome 16?",
        "options": ["Production of zeta and alpha globin chains", "Formation of beta globin chains", "Initiation of haem synthesis", "Synthesis of delta globin chains", "None of the above"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "During deoxygenation of haemoglobin, 2,3-DPG occupies which site?",
        "options": ["Beta-cleft", "Alpha-cleft", "Gamma-cleft", "Delta-cleft", "Haem pocket"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Which of the following are characteristic features of Myelodysplastic Syndromes (MDS)?",
        "options": ["Cytopenia", "Normocellular or hypercellular bone marrow", "Ineffective hematopoiesis", "Decreased risk of leukemia transformation", "Increased dysplasia"],
        "answer": ["T", "T", "T", "F", "T"]
    },
    {
        "question": "Which of these is true regarding the epidemiology of Myelodysplastic Syndromes?",
        "options": ["Median age of diagnosis is 65 years", "Higher incidence in females", "Incidence increases with age", "Most cases are familial", "5q deletion is more common in males"],
        "answer": ["T", "F", "T", "F", "F"]
    },
    {
        "question": "Which of the following are associated with the etiology of MDS?",
        "options": ["Exposure to benzene", "Cigarette smoking", "Fanconi anemia", "Defective apoptosis", "Ionizing radiation"],
        "answer": ["T", "T", "T", "F", "T"]
    },
    {
        "question": "Which mutated genes are linked with a worse prognosis in MDS?",
        "options": ["TP53", "EZH2", "RUNX1", "ASXL1", "JAK2"],
        "answer": ["T", "T", "T", "T", "F"]
    },
    {
        "question": "What are clinical features of MDS related to anemia?",
        "options": ["Fatigue", "Petechiae", "Recurrent infections", "Exercise intolerance", "Pallor"],
        "answer": ["T", "F", "F", "T", "T"]
    },
    {
        "question": "What laboratory findings are consistent with MDS?",
        "options": ["Leukocytosis", "Macrocytic anemia", "Decreased reticulocyte count", "Thrombocytopenia", "Monocytosis in CMML"],
        "answer": ["F", "T", "T", "T", "T"]
    },
    {
        "question": "Which of these are commonly observed in peripheral blood films of MDS patients?",
        "options": ["Pseudo Pelger-Huet anomaly", "Auer rods", "Hypogranulation", "Leukoerythroblastosis", "Ringed sideroblasts"],
        "answer": ["T", "T", "T", "T", "F"]
    },
    {
        "question": "Which are examples of WHO classifications for Myelodysplastic Syndromes?",
        "options": ["MDS with ring sideroblasts", "MDS with multilineage dysplasia", "MDS with excess blasts II", "MDS with isolated del(5q)", "MDS, unclassifiable"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "What are management strategies for low-risk MDS patients?",
        "options": ["Iron chelation therapy", "Erythropoiesis-stimulating agents", "Lenalidomide", "Aggressive chemotherapy", "Luspatercept for SF3B1 mutation"],
        "answer": ["T", "T", "T", "F", "T"]
    },
    {
        "question": "Which conditions should be considered in the differential diagnosis of MDS?",
        "options": ["HIV", "Vitamin B12 deficiency", "Parvovirus B19 infection", "Fanconi anemia", "Chronic alcohol abuse"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Which cytogenetic studies are essential for diagnosing MDS?",
        "options": ["Karyotyping", "FISH", "Flow cytometry", "PCR", "Next-generation sequencing"],
        "answer": ["T", "T", "F", "T", "T"]
    },
    {
        "question": "What are features of bone marrow biopsy in MDS?",
        "options": ["Hypercellularity", "Hypocellularity in 15% of cases", "Abnormal cell distribution", "Fibrosis detection", "Increased lymphocyte proliferation"],
        "answer": ["T", "T", "T", "T", "F"]
    },
    {
        "question": "Which clinical signs may be observed in MDS patients?",
        "options": ["Splenomegaly", "Peripheral edema", "Petechiae", "Heart failure signs", "Ecchymosis"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "What are the subtypes of myelodysplastic/myeloproliferative neoplasms?",
        "options": ["Chronic myelomonocytic leukemia", "Atypical chronic myeloid leukemia", "Juvenile myelomonocytic leukemia", "Refractory anemia with ring sideroblasts", "Unclassifiable MDS/MPN"],
        "answer": ["T", "T", "T", "F", "T"]
    },
    {
        "question": "Which factors are associated with the pathogenesis of MDS?",
        "options": ["Telomerase dysfunction", "Defective DNA repair", "Spliceosome dysregulation", "Abnormal signal transduction", "Vitamin E deficiency"],
        "answer": ["T", "T", "T", "T", "F"]
    },
    {
        "question": "Which of the following is a clinical feature of aplastic anemia?",
        "options": ["Pancytopenia", "Hypocellular bone marrow", "Increased fat cells in bone marrow", "No extensive fibrosis in bone marrow", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "What is the most common cause of acquired aplastic anemia?",
        "options": ["Idiopathic", "Drug-induced", "Viral infections", "Ionizing radiation", "Pregnancy"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Which drugs are associated with drug-induced aplastic anemia?",
        "options": ["Methotrexate", "Chloramphenicol", "Daunorubicin", "Gold salts", "Busulfan"],
        "answer": ["F", "T", "F", "T", "T"]
    },
    {
        "question": "What is a characteristic feature of bone marrow in aplastic anemia?",
        "options": ["<25% cellularity", "Increased fibrosis", "Presence of malignancy", "High levels of hematopoietic cells", "Presence of storage diseases"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Which test is essential for diagnosing aplastic anemia?",
        "options": ["Bone marrow biopsy", "Chromosome breakage test", "Flow cytometry", "Reticulocyte count", "Liver function tests"],
        "answer": ["T", "F", "F", "T", "F"]
    },
    {
        "question": "Inherited causes of aplastic anemia include:",
        "options": ["Fanconi anemia", "Dyskeratosis congenita", "Shwachman-Diamond syndrome", "Diamond-Blackfan anemia", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Fanconi anemia is associated with:",
        "options": ["Autosomal recessive inheritance", "Short stature", "Hypersensitivity to DNA cross-linkers", "High risk of acute myeloid leukemia", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Which of the following is a diagnostic criterion for severe aplastic anemia?",
        "options": ["Bone marrow cellularity <25%", "Neutrophils <0.5 Ã 10â¹/L", "Platelets <20 Ã 10â¹/L", "Reticulocytes <20 Ã 10â¹/L", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Paroxysmal nocturnal hemoglobinuria (PNH) is characterized by:",
        "options": ["Chronic intravascular hemolysis", "Venous thrombosis", "Bone marrow failure", "Deficiency of GPI-linked proteins", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "What is the main mechanism of chronic hemolysis in PNH?",
        "options": ["Absence of CD55 and CD59", "Increased erythropoiesis", "Iron deficiency", "Defective hemoglobin synthesis", "Autoimmune reaction"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Bone marrow failure syndromes result in:",
        "options": ["Pancytopenia", "Increased risk of infections", "Bleeding tendencies", "Fatigue and pallor", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Which of the following is a feature of pure red cell aplasia (PRCA)?",
        "options": ["Absence of erythroblasts in bone marrow", "Severe anemia", "Normal white blood cell count", "Reticulocytopenia", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Which infections are known to cause PRCA?",
        "options": ["Parvovirus B19", "HIV", "Infectious mononucleosis", "Viral hepatitis", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Diamond-Blackfan anemia is characterized by:",
        "options": ["Normochromic macrocytic anemia", "Craniofacial abnormalities", "Thumb abnormalities", "Cardiac malformations", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "What is the treatment of choice for severe aplastic anemia in patients <40 years with an HLA-matched sibling donor?",
        "options": ["Hematopoietic stem cell transplantation", "Immunosuppressive therapy", "Blood transfusions", "Growth factors", "Androgens"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Dyskeratosis congenita is associated with mutations in:",
        "options": ["Telomerase components", "DNA repair enzymes", "Ribosomal protein genes", "HLA antigens", "None of the above"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "What is the primary hematological abnormality in Schwachman-Diamond syndrome?",
        "options": ["Neutropenia", "Pancytopenia", "Myelodysplastic syndrome", "Leukemia", "Thrombocytopenia"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Which of the following syndromes is associated with congenital aplastic anemia and skeletal abnormalities?",
        "options": ["Thrombocytopenia-absent radius syndrome", "Fanconi anemia", "Diamond-Blackfan anemia", "Schwachman-Diamond syndrome", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "What is the treatment for neutropenia in Schwachman-Diamond syndrome?",
        "options": ["G-CSF", "Immunosuppressive therapy", "Stem cell transplantation", "Androgens", "Blood transfusion"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Which malignancies are Fanconi anemia patients at risk of developing?",
        "options": ["Acute myeloid leukemia", "Liver tumors", "Solid organ cancers", "Lymphoma", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "What are common complications of bone marrow transplantation in aplastic anemia?",
        "options": ["Graft failure", "Graft versus host disease", "Infections", "Iron overload", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "What is a key diagnostic marker for PNH?",
        "options": ["Absence of CD55 and CD59 on flow cytometry", "Increased hemoglobin F levels", "Low erythropoietin levels", "Macrocytic anemia", "None of the above"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Aplastic anemia often involves destruction of:",
        "options": ["Hematopoietic stem cells", "Lymphocytes", "Megakaryocytes", "Endothelial cells", "None of the above"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "What is the hallmark hematological finding in Diamond-Blackfan anemia?",
        "options": ["Selective decrease in erythroid precursors", "Leukopenia", "Thrombocytopenia", "Pancytopenia", "Hypersegmented neutrophils"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "What is a key feature of the bone marrow in aplastic anemia?",
        "options": ["Hypocellularity", "Increased fibrosis", "Hypercellularity", "Presence of malignant cells", "All of the above"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Which chromosome encodes the alpha-like globin chains?",
        "options": ["Chromosome 11", "Chromosome 16", "Chromosome 14", "Chromosome 7", "None of the above"],
        "answer": ["F", "T", "F", "F", "F"]
    },
    {
        "question": "What is the most predominant hemoglobin in adults?",
        "options": ["HbA", "HbF", "HbA2", "HbGower I", "HbPortland"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Which hemoglobins are predominant during embryonic life?",
        "options": ["HbGower I", "HbGower II", "HbPortland", "HbA", "HbF"],
        "answer": ["T", "T", "T", "F", "F"]
    },
    {
        "question": "Which genetic mutations are responsible for sickle cell anemia?",
        "options": ["Point mutation in beta-globin gene", "Deletion of alpha-globin gene", "Point mutation in gamma-globin gene", "Insertion in delta-globin gene", "All of the above"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "The mutation causing sickle cell anemia leads to:",
        "options": ["Glutamic acid being replaced by valine", "Glutamic acid being replaced by lysine", "Valine being replaced by glutamic acid", "Lysine being replaced by glutamic acid", "None of the above"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "HbS polymerization occurs in which condition?",
        "options": ["Deoxygenation", "Hyperoxygenation", "Neutral pH", "High temperature", "All of the above"],
        "answer": ["T", "F", "F", "T", "F"]
    },
    {
        "question": "Sickle cell disease results in:",
        "options": ["Vaso-occlusion", "Chronic hemolysis", "Increased red cell deformability", "Normal oxygen transport", "Increased red cell lifespan"],
        "answer": ["T", "T", "F", "F", "F"]
    },
    {
        "question": "Which of the following are features of beta-thalassemia major?",
        "options": ["Severe anemia", "Erythroid hyperplasia", "Hepatosplenomegaly", "Hair-on-end skull appearance", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "What is the primary function of hemoglobin?",
        "options": ["Transport of oxygen", "Transport of carbon dioxide", "Buffering blood pH", "Transport of nitrogen", "All of the above"],
        "answer": ["T", "T", "T", "F", "F"]
    },
    {
        "question": "Which test is most specific for identifying hemoglobinopathies?",
        "options": ["Sickling test", "Hemoglobin electrophoresis", "Complete blood count (CBC)", "Peripheral blood smear", "Bone marrow aspiration"],
        "answer": ["F", "T", "F", "F", "F"]
    },
    {
        "question": "Hydroxyurea benefits patients with sickle cell disease by:",
        "options": ["Increasing HbF levels", "Suppressing HbS polymerization", "Decreasing vaso-occlusive crises", "Reducing chronic hemolysis", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "What are the major chronic complications of sickle cell anemia?",
        "options": ["Stroke", "Pulmonary hypertension", "Chronic leg ulcers", "Avascular necrosis", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Which hemoglobin has the highest oxygen affinity?",
        "options": ["HbF", "HbA", "HbA2", "HbGower I", "HbPortland"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "What is the hallmark of alpha-thalassemia major?",
        "options": ["Hb Bart's (Î³4) formation", "HbH (Î²4) formation", "Absence of alpha chains", "Intrauterine hydrops fetalis", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Which of the following is true about HbA2?",
        "options": ["Composed of alpha and delta chains", "Accounts for 2-3% of adult hemoglobin", "Appears after 6 months of life", "Is predominant in fetal life", "All of the above"],
        "answer": ["T", "T", "T", "F", "F"]
    },
    {
        "question": "Beta-thalassemia results in:",
        "options": ["Excess alpha chains", "Ineffective erythropoiesis", "Hemolysis", "Severe anemia", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "HbC is caused by:",
        "options": ["Lysine replacing glutamic acid", "Valine replacing glutamic acid", "Glutamine replacing glutamic acid", "Serine replacing glutamic acid", "None of the above"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Which hemoglobinopathy offers partial protection against malaria?",
        "options": ["Sickle cell trait", "Beta-thalassemia minor", "HbE", "HbD", "All of the above"],
        "answer": ["T", "T", "F", "F", "F"]
    },
    {
        "question": "Which laboratory finding is characteristic of sickle cell anemia?",
        "options": ["Target cells", "Polychromasia", "Sickle cells", "Howell-Jolly bodies", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Alpha-thalassemia carrier status can be detected by:",
        "options": ["DNA analysis", "Hb electrophoresis", "CBC and peripheral smear", "Oxygen dissociation curve", "None of the above"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "HbH disease is caused by:",
        "options": ["Deletion of three alpha-globin genes", "Point mutation in beta-globin gene", "Deletion of all alpha-globin genes", "Deletion of gamma-globin gene", "None of the above"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "What is the best initial test for suspected sickle cell disease?",
        "options": ["Sickling test", "Hb electrophoresis", "CBC", "Bone marrow biopsy", "Oxygen saturation test"],
        "answer": ["F", "T", "F", "F", "F"]
    },
    {
        "question": "Hb Bart's hydrops fetalis results from:",
        "options": ["Absence of alpha chains", "Excess gamma chains", "Hb Bart's (Î³4) formation", "Severe anemia in utero", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Which thalassemia type is commonly asymptomatic?",
        "options": ["Beta-thalassemia minor", "Alpha-thalassemia trait", "Silent carrier", "HbH disease", "All of the above"],
        "answer": ["T", "T", "T", "F", "F"]
    },
    {
        "question": "Which hemoglobinopathies are detected by Hb electrophoresis?",
        "options": ["HbS", "HbC", "HbD", "HbE", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Which of the following is true about Non-Hodgkin Lymphomas (NHL)?",
        "options": [
            "NHL is a group of clonal lymphoid tumors.",
            "It involves Reed-Sternberg cells.",
            "It often disseminates at the time of diagnosis.",
            "Most cases are derived from NK cells.",
            "NHL is less common than Hodgkinâs lymphoma."
        ],
        "answer": ["T", "F", "T", "F", "F"]
    },
    {
        "question": "What distinguishes Hodgkinâs lymphoma from Non-Hodgkinâs lymphoma?",
        "options": [
            "Presence of Reed-Sternberg cells in Hodgkinâs lymphoma.",
            "Greater predilection for extranodal dissemination in Non-Hodgkinâs lymphoma.",
            "Hodgkinâs lymphoma has a more variable natural history.",
            "NHL has a lower likelihood of dissemination at diagnosis.",
            "Hodgkinâs lymphoma involves mainly T cells."
        ],
        "answer": ["T", "T", "F", "F", "F"]
    },
    {
        "question": "Which of the following translocations is associated with Burkittâs lymphoma?",
        "options": [
            "t(8;14)",
            "t(2;8)",
            "t(11;14)",
            "t(8;22)",
            "t(14;18)"
        ],
        "answer": ["T", "T", "F", "T", "F"]
    },
    {
        "question": "Which of the following viruses is implicated in the etiology of Non-Hodgkin Lymphomas?",
        "options": [
            "Epstein-Barr virus (EBV).",
            "Human T-cell leukemia virus type 1 (HTLV-1).",
            "Human herpesvirus 8 (HHV-8).",
            "Hepatitis C virus (HCV).",
            "Varicella-zoster virus (VZV)."
        ],
        "answer": ["T", "T", "T", "T", "F"]
    },
    {
        "question": "Which of the following is a B-cell lymphoma?",
        "options": [
            "Diffuse large B-cell lymphoma.",
            "Follicular lymphoma.",
            "Mantle cell lymphoma.",
            "Extranodal NK/T-cell lymphoma.",
            "Small lymphocytic lymphoma."
        ],
        "answer": ["T", "T", "T", "F", "T"]
    },
    {
        "question": "Which chromosomal translocation is characteristic of follicular lymphoma?",
        "options": [
            "t(14;18)",
            "t(11;14)",
            "t(8;14)",
            "t(1;14)",
            "t(2;8)"
        ],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Which of the following factors is associated with a worse prognosis in NHL?",
        "options": [
            "Age > 60 years at presentation.",
            "Elevated serum LDH.",
            "Stage I disease.",
            "Presence of bulky disease.",
            "Poor performance status."
        ],
        "answer": ["T", "T", "F", "T", "T"]
    },
    {
        "question": "Which lymphoma subtype is characterized by a 'starry sky' appearance histologically?",
        "options": [
            "Diffuse large B-cell lymphoma.",
            "Burkittâs lymphoma.",
            "Mantle cell lymphoma.",
            "Small lymphocytic lymphoma.",
            "Primary CNS lymphoma."
        ],
        "answer": ["F", "T", "F", "F", "F"]
    },
    {
        "question": "Which bacterial infection is linked to MALT lymphoma?",
        "options": [
            "Helicobacter pylori.",
            "Borrelia burgdorferi.",
            "Campylobacter jejuni.",
            "Chlamydia psittaci.",
            "Streptococcus pneumoniae."
        ],
        "answer": ["T", "T", "T", "T", "F"]
    },
    {
        "question": "Which of the following is a common clinical feature of NHL?",
        "options": [
            "Painless lymphadenopathy.",
            "Night sweats.",
            "Fever > 38Â°C.",
            "Weight gain.",
            "Bone pain."
        ],
        "answer": ["T", "T", "T", "F", "F"]
    },
    {
        "question": "Which lymphoma subtype has a characteristic translocation involving cyclin D1?",
        "options": [
            "Mantle cell lymphoma.",
            "Follicular lymphoma.",
            "Burkittâs lymphoma.",
            "Diffuse large B-cell lymphoma.",
            "Marginal zone lymphoma."
        ],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "What is the main histological finding in diffuse large B-cell lymphoma?",
        "options": [
            "Large tumor cells with prominent nucleoli.",
            "Starry sky pattern.",
            "Small lymphocytes with cleaved nuclei.",
            "Germinal center architecture.",
            "Apoptotic bodies surrounded by macrophages."
        ],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Which of the following subtypes of NHL commonly involves the gastrointestinal tract?",
        "options": [
            "Mantle cell lymphoma.",
            "MALT lymphoma.",
            "Follicular lymphoma.",
            "Burkittâs lymphoma.",
            "Small lymphocytic lymphoma."
        ],
        "answer": ["T", "T", "F", "T", "F"]
    },
    {
        "question": "Which of the following is considered an indolent NHL?",
        "options": [
            "Follicular lymphoma.",
            "Diffuse large B-cell lymphoma.",
            "Mantle cell lymphoma.",
            "Burkittâs lymphoma.",
            "Small lymphocytic lymphoma."
        ],
        "answer": ["T", "F", "T", "F", "T"]
    },
    {
        "question": "Which chromosomal translocation is diagnostic of mantle cell lymphoma?",
        "options": [
            "t(11;14).",
            "t(14;18).",
            "t(8;14).",
            "t(1;14).",
            "t(3;4)."
        ],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Which of the following is a common extranodal site involved in NHL?",
        "options": [
            "Spleen.",
            "CNS.",
            "Liver.",
            "Bone marrow.",
            "Thyroid."
        ],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "What is the typical clinical presentation of Burkittâs lymphoma?",
        "options": [
            "Jaw swelling.",
            "Abdominal masses.",
            "Rapidly enlarging lymph nodes.",
            "Prolonged disease course.",
            "Central nervous system involvement."
        ],
        "answer": ["T", "T", "T", "F", "T"]
    },
    {
        "question": "Which of the following is true about the staging of NHL?",
        "options": [
            "Stage I involves a single lymph node area.",
            "Stage II involves nodes on both sides of the diaphragm.",
            "Stage III involves multiple lymph node areas on the same side of the diaphragm.",
            "Stage IV involves extranodal sites.",
            "Each stage can be further classified as A or B."
        ],
        "answer": ["T", "F", "F", "T", "T"]
    },
    {
        "question": "Which is the most common lymphoma subtype in tropical Africa?",
        "options": [
            "Burkittâs lymphoma.",
            "Diffuse large B-cell lymphoma.",
            "Mantle cell lymphoma.",
            "Small lymphocytic lymphoma.",
            "Follicular lymphoma."
        ],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Which lymphoma is frequently associated with Epstein-Barr virus (EBV) infection?",
        "options": [
            "Endemic Burkittâs lymphoma.",
            "Primary effusion lymphoma.",
            "Splenic marginal zone lymphoma.",
            "T-cell leukemia.",
            "Anaplastic large cell lymphoma."
        ],
        "answer": ["T", "T", "F", "F", "F"]
    },
    {
        "question": "What histological feature characterizes follicular lymphoma?",
        "options": [
            "Presence of centrocytes and centroblasts.",
            "Starry sky pattern.",
            "Diffuse sheets of large cells.",
            "Increased apoptosis.",
            "Prominent nucleoli."
        ],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Which of the following is a feature of aggressive NHL?",
        "options": [
            "Rapidly growing lymphadenopathy.",
            "High cure rates with chemotherapy.",
            "Indolent disease course.",
            "Less frequent extranodal involvement.",
            "No need for CNS prophylaxis."
        ],
        "answer": ["T", "T", "F", "F", "F"]
    },
    {
        "question": "What is the common treatment approach for indolent NHL?",
        "options": [
            "Watchful waiting.",
            "Single-agent chemotherapy.",
            "Combined chemotherapy with CHOP.",
            "CNS prophylaxis.",
            "High-dose therapy with stem cell rescue."
        ],
        "answer": ["T", "T", "F", "F", "F"]
    },
    {
        "question": "Which lymphoma subtype is commonly treated with CHOP regimen?",
        "options": [
            "Diffuse large B-cell lymphoma.",
            "Burkittâs lymphoma.",
            "Mantle cell lymphoma.",
            "MALT lymphoma.",
            "Primary CNS lymphoma."
        ],
        "answer": ["T", "F", "T", "F", "T"]
    },
    {
        "question": "Which of the following is a common clinical manifestation in mantle cell lymphoma?",
        "options": [
            "Generalized lymphadenopathy.",
            "Bone marrow infiltration.",
            "Frequent involvement of extranodal sites.",
            "Starry sky histological appearance.",
            "Painless jaw swelling."
        ],
        "answer": ["T", "T", "T", "F", "F"]
    },
    {
        "question": "Which of the following is a major non-leukaemic myeloproliferative neoplasm (N-MPN)?",
        "options": ["Polycythemia vera (PV)", "Essential thrombocythemia (ET)", "Primary myelofibrosis (PMF)", "Chronic myeloid leukemia (CML)", "All of the above"],
        "answer": ["T", "T", "T", "F", "F"]
    },
    {
        "question": "What mutation is present in over 95% of polycythemia vera cases?",
        "options": ["JAK2V617F mutation", "CALR mutation", "MPL mutation", "TET2 mutation", "None of the above"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Polycythemia vera is associated with which of the following?",
        "options": ["Elevated red cell mass", "Low serum erythropoietin levels", "JAK2 mutation", "Increased risk of acute myeloid leukemia", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Apparent (relative) polycythemia is caused by:",
        "options": ["Dehydration", "Diuretic use", "Smoking", "GaisbÃ¶ck syndrome", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Which of the following is NOT a characteristic feature of essential thrombocythemia (ET)?",
        "options": ["Sustained platelet count â¥450 Ã 10â¹/L", "Risk of thrombotic complications", "Splenic infarctions", "Marked neutrophilia", "Megakaryocytic proliferation"],
        "answer": ["F", "F", "F", "T", "F"]
    },
    {
        "question": "What is the hallmark of primary myelofibrosis (PMF)?",
        "options": ["Bone marrow fibrosis", "Splenomegaly", "Extramedullary hematopoiesis", "Teardrop RBCs", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "What is a key finding in JAK2-positive essential thrombocythemia?",
        "options": ["Higher hemoglobin levels", "Higher white blood cell count", "Increased thrombotic risk", "Increased platelet count", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Which of the following is a risk factor for secondary erythrocytosis?",
        "options": ["High-altitude exposure", "Chronic lung disease", "Erythropoietin administration", "Parathyroid tumors", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Which diagnostic feature differentiates polycythemia vera from secondary erythrocytosis?",
        "options": ["JAK2 mutation positivity", "Increased erythropoietin levels", "Low red cell mass", "Normal platelet counts", "Normal spleen size"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "What is a clinical feature of hyperviscosity in PV?",
        "options": ["Headache", "Visual disturbances", "Dizziness", "Venous thromboembolism", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Aquagenic pruritus in PV is due to:",
        "options": ["Histamine release", "Increased mast cell activity", "Elevated basophil counts", "Warm water exposure", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Which mutation is associated with a lower risk of thrombosis in ET?",
        "options": ["CALR mutation", "JAK2 mutation", "MPL mutation", "TET2 mutation", "None of the above"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "What are the major diagnostic criteria for polycythemia vera according to WHO?",
        "options": ["Elevated hemoglobin or hematocrit", "Bone marrow hypercellularity", "JAK2 mutation", "Low serum erythropoietin", "All of the above"],
        "answer": ["T", "T", "T", "F", "T"]
    },
    {
        "question": "Complications of essential thrombocythemia include:",
        "options": ["Thrombosis", "Myelofibrotic transformation", "Acute myeloid leukemia", "Pregnancy loss", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "What is the most feared complication of polycythemia vera?",
        "options": ["Leukemic transformation", "Myelofibrosis", "Hyperviscosity syndrome", "Thrombosis", "Splenomegaly"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "The JAK2 mutation leads to:",
        "options": ["Hypersensitivity to erythropoietin", "Panmyelosis", "Autonomous erythropoiesis", "Prothrombotic state", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Which agent is commonly used to reduce hematocrit in PV?",
        "options": ["Hydroxyurea", "Interferon-alpha", "Phlebotomy", "Ruxolitinib", "All of the above"],
        "answer": ["F", "F", "T", "F", "F"]
    },
    {
        "question": "What is the characteristic blood smear finding in primary myelofibrosis?",
        "options": ["Teardrop cells", "Leukoerythroblastosis", "Giant platelets", "Normochromic RBCs", "All of the above"],
        "answer": ["T", "T", "T", "F", "F"]
    },
    {
        "question": "Busulfan is used in PV treatment when:",
        "options": ["Other treatments fail", "Leukemic transformation occurs", "There is severe pruritus", "The patient has a high platelet count", "All of the above"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Which cytokine contributes to bone marrow fibrosis in PMF?",
        "options": ["TGF-beta", "PDGF", "IL-1", "bFGF", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "In ET, what is the hallmark finding on bone marrow biopsy?",
        "options": ["Megakaryocyte proliferation", "Increased cellularity", "Hypocellular marrow in MPL mutation", "Giant megakaryocytes", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Splenomegaly in PMF is due to:",
        "options": ["Extramedullary hematopoiesis", "Splenic infarction", "Portal hypertension", "Leukemic infiltration", "None of the above"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Which patient group in ET is considered low risk?",
        "options": ["Age <40 years", "No prior thrombosis", "Platelet count <1500 Ã 10â¹/L", "No JAK2 mutation", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "Which drug is FDA-approved for PV treatment?",
        "options": ["Ruxolitinib", "Hydroxyurea", "Ropeginterferon alfa-2b", "Anagrelide", "All of the above"],
        "answer": ["F", "F", "T", "F", "F"]
    },
    {
        "question": "Secondary thrombocytosis is commonly caused by:",
        "options": ["Acute infection", "Iron deficiency", "Splenectomy", "Drug use", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "What is the median survival in primary myelofibrosis with treatment?",
        "options": ["3-5 years", "10 years", "15 years", "5-7 years", "None of the above"],
        "answer": ["T", "F", "F", "F", "F"]
    },
    {
        "question": "Which symptom is associated with hypermetabolism in PV?",
        "options": ["Weight loss", "Night sweats", "Fever", "Increased appetite", "All of the above"],
        "answer": ["T", "T", "T", "F", "F"]
    },
    {
        "question": "Reactive thrombocytosis can result from:",
        "options": ["Chronic inflammation", "Surgery", "Recovery from thrombocytopenia", "Acute blood loss", "All of the above"],
        "answer": ["T", "T", "T", "T", "T"]
    },
    {
        "question": "What distinguishes pre-fibrotic PMF from overt PMF?",
        "options": ["Bone marrow findings", "Splenomegaly", "Peripheral blood changes", "Presence of mutations", "All of the above"],
        "answer": ["T", "T", "T", "F", "T"]
    }
]

